Status | Study |
Active, not recruiting |
Study Name: Avastin/Radiation (XRT)/Temozolomide (Temodar) Followed by Avastin/Temodar/Topotecan for Glioblastoma Condition: Malignant Glioma Glioblastoma Multiforme Date: 2009-10-28 Interventions: Drug: Bevacizumab Bevacizumab |
Completed |
Study Name: Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme Condition: Glioblastoma Multiforme Gliosarcoma Date: 2009-09-15 Interventions: Drug: Avastin Avastin, by intr |
Active, not recruiting |
Study Name: Hyperbaric Hyperoxygenation With Radiotherapy and Temozolomide in Adults With Newly Diagnosed Glioblastoma Condition: Glioblastomas Gliosarcoma Date: 2009-07-07 Interventions: Other: Hyperbaric Oxygen Therapy in addition to standard radiation and chemotherapy, you will also recei |
Completed |
Study Name: Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma Condition: Glioblastoma Gliosarcoma Date: 2008-08-12 Interventions: Drug: Temozolomide |
Completed |
Study Name: Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas Condition: Glioblastoma Gliosarcoma Date: 2008-01-29 Interventions: Drug: Avastin and Temozolomide This is Phase II study with the combination of Avastin & Temozolomide |
Completed |
Study Name: Avastin in Combination With Radiation (XRT) & Temozolomide, Followed by Avastin, Temozolomide and Irinotecan for Glioblastoma (GBM) and Gliosarcomas Condition: Glioblastoma Gliosarcoma Brai Date: 2008-01-10 Interventions: Drug: Avastin Avastin will be |
Completed |
Study Name: Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma Condition: Glioblastoma Gliosarcoma Date: 2007-09-04 Interventions: Drug: Bevacizumab Patients are |
Completed |
Study Name: Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma Condition: Adult Glioblastoma Adult Gliosarcoma Date: 2007-02-08 Interventions: Drug: irinotecan hydrochloride |
Completed |
Study Name: Phase 1/2 Study in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients Condition: Glioblastoma Glioblastoma Multiforme Date: 2006-11-17 Interventions: Drug: enzastaurin Phase 1 - 25 |
Terminated |
Study Name: Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma Condition: Adult Brain Tumors Date: 2006-10-12 Interventions: Drug: erlotinib hydrochloride Tarceva will be self-administered in an open-label, unblinded manner to al |